Drug Information

Drug General Information
Drug ID
D0F7AT
Former ID
DAP000479
Drug Name
Cryptenamine Acetates
Synonyms
Unitensen; Cryptenamine Tannates; Cryptenamine Acetates
Indication Hypertension [ICD9: 401; ICD10:I10-I16] Approved [551871]
Therapeutic Class
Cardiovascular Agents
Company
Medpointe Pharmaceuticals Medpointe Healthcare Inc
Formula
C28H46O10N
CAS Number
CAS 1356-18-9
Target and Pathway
Target(s) Muscarinic acetylcholine receptor M5 Target Info Modulator [556264]
KEGG Pathway Calcium signaling pathway
Neuroactive ligand-receptor interaction
Cholinergic synapse
Regulation of actin cytoskeleton
PANTHER Pathway Alzheimer disease-amyloid secretase pathway
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway
Reactome Muscarinic acetylcholine receptors
G alpha (q) signalling events
WikiPathways Monoamine GPCRs
Calcium Regulation in the Cardiac Cell
Regulation of Actin Cytoskeleton
GPCRs, Class A Rhodopsin-like
Gastrin-CREB signalling pathway via PKC and MAPK
GPCR ligand binding
GPCR downstream signaling
References
Ref 551871Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
Ref 556264Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.